BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 38614870)

  • 1. Application of Machine Learning for Classification of Brain Tumors: A Systematic Review and Meta-Analysis.
    Silva Santana L; Borges Camargo Diniz J; Mothé Glioche Gasparri L; Buccaran Canto A; Batista Dos Reis S; Santana Neville Ribeiro I; Gadelha Figueiredo E; Paulo Mota Telles J
    World Neurosurg; 2024 Jun; 186():204-218.e2. PubMed ID: 38580093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AI-based classification of three common malignant tumors in neuro-oncology: A multi-institutional comparison of machine learning and deep learning methods.
    Bathla G; Dhruba DD; Soni N; Liu Y; Larson NB; Kassmeyer BA; Mohan S; Roberts-Wolfe D; Rathore S; Le NH; Zhang H; Sonka M; Priya S
    J Neuroradiol; 2024 May; 51(3):258-264. PubMed ID: 37652263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of the Efficacy of Raman Spectroscopy and Machine-Learning-Based Identification of Glioma Tissue.
    Goff NK; Ashby L; Ashour R
    World Neurosurg; 2024 May; ():. PubMed ID: 38796149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
    Nguyen AV; Blears EE; Ross E; Lall RR; Ortega-Barnett J
    Neurosurg Focus; 2018 Nov; 45(5):E5. PubMed ID: 30453459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
    J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
    Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis.
    Guha A; Goda JS; Dasgupta A; Mahajan A; Halder S; Gawde J; Talole S
    Front Oncol; 2022; 12():884173. PubMed ID: 36263203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of DWI for differentiating primary central nervous system lymphoma from glioblastoma: a systematic review and meta-analysis.
    Lu X; Xu W; Wei Y; Li T; Gao L; Fu X; Yao Y; Wang L
    Neurol Sci; 2019 May; 40(5):947-956. PubMed ID: 30706241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.
    Guha A; Halder S; Shinde SH; Gawde J; Munnolli S; Talole S; Goda JS
    Clin Radiol; 2024 Jun; 79(6):460-472. PubMed ID: 38614870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.
    Xu W; Wang Q; Shao A; Xu B; Zhang J
    PLoS One; 2017; 12(3):e0173430. PubMed ID: 28301491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.
    Zhao J; Huang Y; Song Y; Xie D; Hu M; Qiu H; Chu J
    Eur Radiol; 2020 Aug; 30(8):4664-4674. PubMed ID: 32193643
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.